Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1996-07-31
1998-08-04
Eisenschenk, Frank C.
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
424 9351, 4241811, 4241831, 435 7021, 4351723, 435328, 4353431, 435344, 4353201, 5303877, 53038873, 5303888, 5303913, 5303917, A61K 39395, C12P 2108, C12N 1513, C07K 1646
Patent
active
057895546
ABSTRACT:
A chimeric LL2 monoclonal antibody is described in which the complementarity determining regions (CDRs) of the light and heavy chains of the murine LL2 anti-B-lymphoma, anti-leukemia cell monoclonal antibody has been recombinantly joined to the human kappa and IgG.sub.1 constant region domains, respectively, which retains the immunospecificity and B-cell lymphoma and leukemia cell internalization capacity of the parental murine LL2 monoclonal antibody, and which has the potential of exhibiting reduced human anti-mouse antibody production activity. A humanized LL2 monoclonal antibody is described in which the CDRs of the light and heavy chains have been recombinantly joined to a framework sequence of human light and heavy chains variable regions, respectively, and subsequently linked to human kappa and IgG.sub.1 constant region domains, respectively, which retains the immunospecificity and B-lymphoma and leukemia cell internalization capacities of the parental murine and chimeric LL2 monoclonal antibodies, and which has the potential for exhibiting reduced human anti-mouse antibody production activity. Vectors for producing recombinant chimeric and humanized chimeric monoclonal antibodies are provided. Isolated DNAs encoding the amino acid sequences of the LL2 variable light and heavy chain and CDR framework regions are described. Conjugates of chimeric and humanized chimeric LL2 antibodies with cytotoxic agents or labels find use in therapy and diagnosis of B-cell lymphomas and leukemias.
REFERENCES:
patent: 5057313 (1991-10-01), Shih et al.
Gussow, D and Seeman, G. Meth. in Enz. 203: 99-121, 1991.
Morrison, SL et al. Proc. Nat. Acad. Sci. (USA). 81: 6851-6855, Nov. 1984.
Belise et al., "Epitope specificity of the anti-B-cell lymphoma monoclonal antibody, L.L.2" Proc. of the Am. Assn. for Can. Res., vol. 34, p. 481, #2873 (Mar. 1993).
Mills, George Q, M.D., "Diagnostic imaging of non-Hodgkin's B-cell lymphoma with anti-lymphomas antibody labeled with Tc-99m", Baton Rouge, LA 70808, Proc. of the Am. Assn. for Can. Res., vol. 34, p. 479 (Mar. 1993), Abst. #2857.
Kreitman, Robert J. et al., "Pseudomonas Exotoxin-based Immunotoxins Containing the Antibody LL2 or LL2-Fab' Induce Regression of Subcutaneous Human B-Cell Lymphoma in Mice", Can. Res. 53, pp. 819-825 (Feb. 15, 1993).
Thorpe, Robin, "Monoclonal antibodies: clinical and regulatory issues", TIBTECH, vol. 11, pp. 40-42 (Feb. 1993).
Goldenberg, David M., "Radiolabeled Antibodies", Scientific. Am. Sci. & Med., pp. 64-73, (Mar./Apr. 1994).
Shih, Lisa B. et al., "Internalization and Intracellular Processing of an Anti-B Cell Lymphoma Monoclonal Antibody, LL2", Int. J. Cancer: 56, pp. 538-545 (1994).
Goldenberg, David M., "Targeting, Dosimetry, and Radioimmunotherapy of B-Cell Lymphomas with Iodine-131-Labeled LL2 Monoclonal Antibody", J. of Clin. Onc., vol. 9, No. 4, pp. 548-564 (Apr. 1991).
Hansen Hans
Leung Shui-on
Eisenschenk Frank C.
Immunomedics Inc.
VanderVegt F. Pierre
LandOfFree
Immunoconjugates and humanized antibodies specific for B-cell ly does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunoconjugates and humanized antibodies specific for B-cell ly, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunoconjugates and humanized antibodies specific for B-cell ly will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1178401